Teknova and Pluristyx be part of arms to streamline next-generation cell remedy manufacturing


  • Alpha Teknova (NASDAQ:TKNO), and Pluristyx Tuesday stated  that the businesses are collaborating to provide and commercialize Pluristyx’s PluriFreeze product line.
  • Pluristyx launched the PluriFreeze product line as a protecting wash paired with a cryopreservative designed to simplify the scale-up course of for corporations working to deliver allogeneic cell therapies to market.
  • The collaboration between Pluristyx and Teknova will allow wider buyer entry to PluriFreeze by making Teknova the unique producer and distributor in the USA and Canada

Leave a Reply

Your email address will not be published. Required fields are marked *